The Moultrie Observer Biogen will stop selling its controversial Alzheimer's drug Aduhelm Plantation Trace • Feb 1, 2024
Daily Citizen | Dalton Alzheimer's Association welcomes FDA approval of Leqembi Historic High Country • Jul 8, 2023
Union Recorder | Milledgeville Alzheimer's drug shows promise in early results of study Historic Heartland • Sep 28, 2022
Jackson Progress Argus Alzheimer's drug slows progression of cognitive decline in clinical trial, drugmakers say Historic Heartland • Sep 28, 2022
Atlanta Daily World Biogen's Community Advisory Board Helps Biogen Promote Diversity in Clinical Research Metro Atlanta • May 10, 2022
WLTZ | Georgia News Columbus Research Facility on the Verge of Alzheimer's Game Changer Presidential Pathways • Jan 6, 2020
Times Georgian | Carrollton Biogen Inc. reanalyzes studies,presses ahead on Alzheimer's drug Historic High Country • Oct 24, 2019
Jackson Progress Argus Drugmaker reverses course, plans to seek FDA approval for Alzheimer's treatment Historic Heartland • Oct 22, 2019
WXIA 11 NBC Atlanta Couple vows to fights Alzheimer's one step at a time Metro Atlanta • Apr 17, 2019
Ledger Enquirer | Business Biogen and Guess slide while Darden and Micron rise Georgia Business • Mar 21, 2019